🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the recommended Phase IIa dose (RP2D) of the triplet combinati...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2024-12-31
Trial ID
NCT06683755
Treatments Being Tested
This is a Phase 1 open-label, study designed to characterize the safety, to...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2024-11-06
Trial ID
NCT05629546
Treatments Being Tested
This is a Phase 2 clinical trial with a 2:1 randomization comparing neoadju...
Status
Recruiting
Location
University of California, Irvine
Start Date
2025-08-21
Trial ID
NCT06624475
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness and safety of re...
Status
Completed
Location
Local Institution - 0010
Start Date
2021-02-04
Trial ID
NCT04567615
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of ne...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center
Start Date
2021-05-28
Trial ID
NCT04658147
Treatments Being Tested
This is a Phase 1B study assessing the safety of immune checkpoint inhibiti...
Status
Active Not Recruiting
Location
Johns Hopkins University
Start Date
2019-03-06
Trial ID
NCT03610711
Treatments Being Tested
In this Phase II trial of personalized immunotherapy in R/M HNSCC, gene exp...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-05-14
Trial ID
NCT04326257
Treatments Being Tested
Melanoma remains a common cancer with rising incidence, and despite signifi...
Status
Not Yet Recruiting
Location
HFR Fribourg
Start Date
2026-09
Trial ID
NCT07574047
Treatments Being Tested
The primary objective of this study is to determine the feasibility of four...
Status
Completed
Location
Jessa Hospital Hasselt
Start Date
2020-03-04
Trial ID
NCT04205552
Treatments Being Tested
Background: Glioblastoma (GBM) brain tumors almost always return after tre...
Status
Completed
Location
Emory University
Start Date
2018-09-24
Trial ID
NCT03493932
Treatments Being Tested